Overview
- Covers regulatory and manufacturing aspects of 3D printing in drug development
- Particular focus on hot melt extrusion and extruded filaments suitable for optimizing 3D printing
- Thorough short text and guide for use on the production line of 3D printing of pharmaceuticals
Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series (AAPS, volume 44)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
This inclusive text describes 3D Printing for pharmaceutical applications, including emerging 3D technologies. The book focuses on the functionality of the materials/biomaterials used for the preparation of dosage forms and devices, fundamentals for preparing these systems and novel applications using these additive manufacturing techniques. Also, the text includes clinical relevance and regulatory considerations for the future of personalized medicine.
Authored by experts with a broad range of experience, extensive insight into the science of 3D printing technology used to produce these systems is provided. Highlighting viewpoints from the academic, polymer excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying techniques of additive manufacturing for drug product and device development whilealso providing insight into the path forward for the technology in years to come.
Authored by experts with a broad range of experience, extensive insight into the science of 3D printing technology used to produce these systems is provided. Highlighting viewpoints from the academic, polymer excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying techniques of additive manufacturing for drug product and device development whilealso providing insight into the path forward for the technology in years to come.
Similar content being viewed by others
Keywords
Table of contents (11 chapters)
-
Front Matter
-
Introduction, Clinical, and Regulatory Landscape
-
Front Matter
-
-
3D Printing Design and Formulation Technologies
-
Front Matter
-
-
Personalized Medicine and Future Trends
-
Front Matter
-
-
Back Matter
Editors and Affiliations
About the editors
Dr. Michael A. Repka is Distinguished Professor of the Department of Pharmaceutics at The University of Mississippi. He is also Founder and Director of the Pii Center for Pharmaceutical Technology. His research interests include the solubilization and delivery of poorly soluble bioactives via Hot Melt Extrusion (HME) technology, while coupling HME techniques with 3D printing to produce patient centric delivery systems . Dr. Repka has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks.
Dr. Nigel Langley is currently the Global Technical Director, Life Sciences at Gaylord Chemical LLC. He has a strong interest in excipient innovation, solubilization, hot melt extrusion and 3D printing. Dr. Langley has also worked at BASF and Croda International PLC and is the current Chair of IPEC-Americas.
Dr. Nigel Langley is currently the Global Technical Director, Life Sciences at Gaylord Chemical LLC. He has a strong interest in excipient innovation, solubilization, hot melt extrusion and 3D printing. Dr. Langley has also worked at BASF and Croda International PLC and is the current Chair of IPEC-Americas.
Bibliographic Information
Book Title: 3D Printing
Book Subtitle: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development
Editors: Michael A. Repka, Nigel Langley
Series Title: AAPS Advances in the Pharmaceutical Sciences Series
DOI: https://doi.org/10.1007/978-3-031-46015-9
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: American Association of Pharmaceuticals Sciences 2024
Hardcover ISBN: 978-3-031-46014-2Published: 02 December 2023
Softcover ISBN: 978-3-031-46017-3Due: 02 January 2024
eBook ISBN: 978-3-031-46015-9Published: 01 December 2023
Series ISSN: 2210-7371
Series E-ISSN: 2210-738X
Edition Number: 1
Number of Pages: XI, 288
Number of Illustrations: 6 b/w illustrations, 94 illustrations in colour
Topics: Pharmaceutical Sciences/Technology, Pharmacology/Toxicology, Biotechnology, Biological Techniques